Protagonist Therapeutics PTGX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $6.73B.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's market capitalization?
- Protagonist Therapeutics (PTGX) reported market capitalization of $6.73B in Q1 2026.
- How has Protagonist Therapeutics's market capitalization changed year-over-year?
- Protagonist Therapeutics's market capitalization increased by 126.6% year-over-year, from $2.97B to $6.73B.
- What is the long-term trend for Protagonist Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's market capitalization has grown at a 41.5% compound annual growth rate (CAGR), from $962.2M to $5.46B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.